CAERUS CONSULTING AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board: TV
Torgeir Vaage1964
Years since formation: 16 years; since May 9, 2009
Type: Limited company
VAT registered: Yes
Number of employees: 0

Ownership

Number of shares and share classes: 10; 1 share class
Total number of shareholders: 1; person

Financials

Total operating income 2023: 5,096,950; NOK
Annual total result 2023: 3,789,421; NOK
Total equity 2023: 7,719,249; NOK

Last update: Jan 3, 2025

Management

Board

Name	Role	Shares
TV Torgeir Vaage 1964	Chairman	100 % directly
SA Sissel Annie Nuth Davidsson 1965	Board Member	-

Others

Name	Role	Shares
S SPAREBANK 1 REGNSKAPSHUSET SØRØST-NORGE AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
TV Torgeir Vaage 1964	Chairman	100 % directly

Last update: Jan 16, 2025

Ownership

Company shareholders

Name	Share class	Number of shares	Share
TV Torgeir Vaage 1964	Ordinary shares	10	100 %

Shares owned by the CAERUS CONSULTING AS

Name	Share class	Number of shares	Share
S STOREBRAND ASA	NO0003053605	1,000	< 0.01 %
D DNO ASA	NO0003921009	10,000	< 0.01 %
A AKER HORIZONS ASA	NO0010921232	5,000	< 0.01 %
A ABG SUNDAL COLLIER HOLDING ASA	NO0003021909	20,000	< 0.01 %
Y YARA INTERNATIONAL ASA	NO0010208051	250	< 0.01 %
A AKER BP ASA	NO0010345853	400	< 0.01 %
P PARETO BANK ASA	NO0010397581	8,000	< 0.01 %

Last update: May 24, 2024

Financials

in NOK

Summary

Year	2023	2022
Total operating income	5,096,950	5,421,733
Annual Total Result	3,789,421	4,253,937
Total assets	7,961,490	6,206,051
Total liabilities	242,242	1,276,223
Total equity	7,719,249	4,929,828

P&L

Year	2023	2022
Total operating income	5,096,950	5,421,733
Total operating costs	1,339,405	1,507,718
Operating result	3,757,545	3,914,015
Financial income/costs	61,310	339,923
Profit before tax	3,818,856	4,253,937
Total tax & extraordinary income/cost	29,435	0
Annual Total Result	3,789,421	4,253,937

Balance overview

Year	2023	2022
Total fixed assets	418,228	418,228
Total current assets	7,543,262	5,787,823
Total assets	7,961,490	6,206,051
Short term debt	242,242	1,276,223
Long term debt	0	0
Total liabilities	242,242	1,276,223
Contributed capital	846,404	1,846,404
Retained earnings	6,872,845	3,083,424
Total equity	7,719,249	4,929,828
Total equity and liabilities	7,961,490	6,206,051

CAERUS CONSULTING AS994 038 567